Form 4 for TMDX TransMedics Group, Inc.
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-20 · accession 0000899243-23-005895 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-22 | 2023-02-20 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | A - Grant | $0.00 | +37.3K | 426.4K | +10% | $0 |
| D | 2023-02-22 | 2023-02-20 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | A - Grant | $0.00 | +57.2K | 57.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-20 | A | A | 37,332 | $0.00 | 426,444 | D | — | — | (F1) Includes 37,332 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-02-20 | A | A | 57,165 | $0.00 | 57,165 | D | $66.10 · — to 2033-02-20 | 57,165 Common Stock | (F2) The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service. |